Dear Editor,
As we known, pigs play a vital role as genetic mixing vessels for human and avian influenza viruses as their tracheal epitheliums possess both sialic acid a-2,6-Gal and a-2,3-Gal receptors (Ma et al. 2008) , and swine influenza viruses occasionally infect humans (Shinde et al. 2009 ).
The Eurasian avian-like swine influenza A (H1N1) virus (EAS-H1N1) spread into China around 2007, when the first isolate (A/swine/Fujian/204/2007) from pigs in Fujian was reported via swine influenza surveillance program (Liu et al. 2009 ). Much later, three cases of EAS-H1N1 infection in human were reported in China and they were all children under the age of three (Yang et al. 2012; Wang et al. 2013; Zhu et al. 2016) , whereas the forth case was an adult, who was confirmed in October, 2016, in Fujian province.
The patient was a 46-year-old man with fever of 39°C and started coughing on October 19, 2016. In the day after onset, he was treated in a prefectural hospital on account of hemoptysis and dyspnea, and then he was transferred to the intensive care unit (ICU) of Fuzhou Pulmonary Hospital because of severe pneumonia on October 21. A throat-swab specimen of patient was collected and transferred to Fujian CDC rapidly with cryogenic storage container for confirming influenza virus. Clinical examination revealed white blood cell (WBC) count of 5.4 9 10 9 /L, blood platelet count of 27 9 10 9 /L, and creatinine 300 lmol/L. At last, the patient died on October 28 due to multi-organ failure.
A retrospective investigation was conducted to identify the potential infection source and any other possible cases. The patient lived with his wife, son, brother and sister in an argillous house, with pigs, chickens, and ducks being bred around it. The patient had not the history of feeding poultry or swine and visiting live poultry market before he got sick. A total of 9 close contacts (6 family members and 3 healthcare workers) of the patient did not develop any influenza-like symptoms during the longest incubation period. On October 23, we collected 12 specimens (including 3 poultry drinking water samples, 3 poultry cage surface wipes, 1 chicken feces sample, 3 duck feces samples and 2 pig feces samples) from the surrounding environment where the patient lived, but no influenza viruses were identified at that time.
A throat-swab specimen of the patient was collected and the virus was isolated using 9-to-10-days-old specific pathogen-free (SPF) embryonated chicken eggs in the Biosafety Level 3 Laboratory, terming influenza A/Fujiancangshan/SWL624/2016 (FJ/624/16) virus. To study the genomic characterization of FJ/624/16 virus, we sequenced the complete genomes of the viral isolate in November, 2016. Sequences were assembled using the SeqMan of the Lasergene Package (DNAStar Corporation, USA). Nucleotide alignments and phylogenetic tree were constructed using the MEGA version 6.0 software (the Biodesign Institute, USA) by the Neighbor-Joining method with 1000 bootstrap replicates as implemented. Phylogenetic analysis of genome showed that the isolate was a novel triple-reassortant H1N1 virus with genes containing from Eurasian avian-like swine (HA, NA), A (H1N1) pdm09 (PB2, PB1, PA, NP, M) and classical swine (NS) lineages (Tables 1, 2 We compared the newly sequenced genomes with 3 available genomes of human influenza virus strains in public databases to determine if they had attained key molecular features associated with increased virulence in mammals, mammalian transmissibility, and antiviral resistance (Table 3) . In this study, FJ/624/16 possessed E190D and D225E (H3 numbering) in HA protein, suggesting the preference to a-2,6-linked sialosides and increase in the binding force of H1N1 virus in human upper respiratory tract (Matrosovich et al. 2000; Zhu et al. 2016) . FJ/624/16 was found to contain an amino acid motif PSIQSR * GL at its HA cleavage sites, a characteristic of low pathogenic influenza virus (Korteweg and Gu 2008) . The amino acid substitutions (H274Y, N294S, et al.) associated with neuraminindase inhibitory drugs were not observed in the NA protein of FJ/624/16, indicating sensitivity to neuramidinase inhibitors, but an S31N substitution in M2 protein suggested resistant to adamantanes. In addition, our data showed that several amino acid residues of FJ/624/16 might increase viral virulence or adaptation in mammals, such as 89V and 591R in the PB2, 336M, 356R and 409N in the PA, 215A in the M1, and 42S in the NS1 (Nguyen et al. 2012; Gao et al. 2013; Yamada et al. 2010; Wang et al. 2016; Fan et al. 2009; Jiao et al. 2008) .
So far, a total of 4 human cases of Eurasian avian-like swine influenza A (H1N1) virus infection had been reported in China. All three cases reported previously were children under 3 years old, but the first adult case-patient was confirmed in China in this study, signifying the EAS-H1N1 virus infection was not confined to children. The 8 gene segments of human infection with EAS-H1N1 virus reported in China during 2011-2012 originated from Eurasian avian influenza virus, however, the two EAS-H1N1 viruses reported in China lately differed from those: HA and NA gene clustered with Eurasian avian influenza virus, and other 6 genes shared the closely related with A (H1N1) pdm09 virus or classical swine influenza virus by phylogenetic analysis, implying that the genes of A (H1N1) pdm09 virus might have been recombined in swine since 2009. According to previous reports and this study, human To analyze the virulence, transmissibility and drugresistance of the EAS-H1N1 virus from the adult patient, we performed an in-depth analysis of genetic characteristics of the FJ/624/16 virus. The virus might preferentially bind to influenza virus-binding receptor of human upper respiratory tract due to the amino acid mutations E190D and D225E within HA protein, hinting the potential risk of human-to-human transmission. In addition, several amino acid residues of FJ/624/16 virus might increase viral virulence or adaptation in mammals, so the severity of disease caused by EAS-H1N1 should be valued in future studies. In our study, we found that the virus was resistant to adamantanes and sensitive to neuramidinase inhibitors, suggesting that early administration of oseltamivir or peramivir may help to reduce the severity of the disease.
In summary, human infection with the EAS-H1N1 virus could lead to severe clinical syndrome, even death. However, increasing evidences show that the EAS-H1N1 virus becomes more adaptative to mammal infection, and was equipped with viral molecular basis of cross-species transmission (Yang et al. 2012; Wang et al. 2013; Zhu et al. 2016; Qi et al. 2012) . Thus, it is a great significance to strengthen the surveillance for EAS-H1N1 virus among swine and humans, and virologic analyses to assess genetic changes of EAS-H1N1 virus also highlighted the great value to determine the viral transmissibility among humans and pandemic potential. 
